Drug Shortage Report for TEVA-ROSUVASTATIN

Last updated on 2021-04-15 History
Report ID 120241
Drug Identification Number 02354616
Brand name TEVA-ROSUVASTATIN
Common or Proper name ROSUVASTATIN 10MG TAB
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) ROSUVASTATIN
Strength(s) 10MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 500
ATC code C10AA
ATC description LIPID MODIFYING AGENTS, PLAIN
Reason for shortage Shortage of an inactive ingredient or component.
Anticipated start date
Actual start date 2020-07-14
Estimated end date 2021-04-30
Actual end date 2021-04-14
Shortage status Resolved
Updated date 2021-04-15
Company comments Allocating 100% of Teva market share.
Health Canada comments
Tier 3 Status No
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v21 2021-03-25 French Compare
v22 2021-04-01 English Compare
v23 2021-04-01 French Compare
v24 2021-04-15 English Compare
v25 2021-04-15 French Compare

Showing 21 to 25 of 25